Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 303

1.

MYC-induced cancer cell energy metabolism and therapeutic opportunities.

Dang CV, Le A, Gao P.

Clin Cancer Res. 2009 Nov 1;15(21):6479-83. doi: 10.1158/1078-0432.CCR-09-0889. Epub 2009 Oct 27. Review.

2.

Rethinking the Warburg effect with Myc micromanaging glutamine metabolism.

Dang CV.

Cancer Res. 2010 Feb 1;70(3):859-62. doi: 10.1158/0008-5472.CAN-09-3556. Epub 2010 Jan 19. Review.

3.

The interplay between MYC and HIF in the Warburg effect.

Dang CV.

Ernst Schering Found Symp Proc. 2007;(4):35-53. Review.

PMID:
18811052
4.

Therapeutic targeting of Myc-reprogrammed cancer cell metabolism.

Dang CV.

Cold Spring Harb Symp Quant Biol. 2011;76:369-74. doi: 10.1101/sqb.2011.76.011296. Epub 2011 Sep 29. Review.

PMID:
21960526
5.

c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism.

Gao P, Tchernyshyov I, Chang TC, Lee YS, Kita K, Ochi T, Zeller KI, De Marzo AM, Van Eyk JE, Mendell JT, Dang CV.

Nature. 2009 Apr 9;458(7239):762-5. doi: 10.1038/nature07823. Epub 2009 Feb 15.

7.

MYC, microRNAs and glutamine addiction in cancers.

Dang CV.

Cell Cycle. 2009 Oct 15;8(20):3243-5. Epub 2009 Oct 15.

PMID:
19806017
8.

MYC, metabolism, cell growth, and tumorigenesis.

Dang CV.

Cold Spring Harb Perspect Med. 2013 Aug 1;3(8). pii: a014217. doi: 10.1101/cshperspect.a014217.

9.

Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expression.

Xu X, Li J, Sun X, Guo Y, Chu D, Wei L, Li X, Yang G, Liu X, Yao L, Zhang J, Shen L.

Oncotarget. 2015 Sep 22;6(28):26161-76. doi: 10.18632/oncotarget.4544.

10.

MYC on the path to cancer.

Dang CV.

Cell. 2012 Mar 30;149(1):22-35. doi: 10.1016/j.cell.2012.03.003. Review.

11.
12.

Carrot and stick: HIF-alpha engages c-Myc in hypoxic adaptation.

Huang LE.

Cell Death Differ. 2008 Apr;15(4):672-7. doi: 10.1038/sj.cdd.4402302. Epub 2008 Jan 11. Review.

13.

Glucose metabolism and cancer.

Shaw RJ.

Curr Opin Cell Biol. 2006 Dec;18(6):598-608. Epub 2006 Oct 12. Review.

PMID:
17046224
14.

Regulation of glycolysis and the Warburg effect by estrogen-related receptors.

Cai Q, Lin T, Kamarajugadda S, Lu J.

Oncogene. 2013 Apr 18;32(16):2079-86. doi: 10.1038/onc.2012.221. Epub 2012 Jun 4.

15.

Waves of gene regulation suppress and then restore oxidative phosphorylation in cancer cells.

Smolková K, Plecitá-Hlavatá L, Bellance N, Benard G, Rossignol R, Ježek P.

Int J Biochem Cell Biol. 2011 Jul;43(7):950-68. doi: 10.1016/j.biocel.2010.05.003. Epub 2010 May 10. Review.

PMID:
20460169
16.

Hypoxia-inducible factor 1 and cancer pathogenesis.

Semenza GL.

IUBMB Life. 2008 Sep;60(9):591-7. doi: 10.1002/iub.93. Review.

17.

Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth.

Gaglio D, Metallo CM, Gameiro PA, Hiller K, Danna LS, Balestrieri C, Alberghina L, Stephanopoulos G, Chiaradonna F.

Mol Syst Biol. 2011 Aug 16;7:523. doi: 10.1038/msb.2011.56.

18.

Hypoxia induces differential translation of enolase/MBP-1.

Sedoris KC, Thomas SD, Miller DM.

BMC Cancer. 2010 Apr 22;10:157. doi: 10.1186/1471-2407-10-157.

19.

Roles of p53, MYC and HIF-1 in regulating glycolysis - the seventh hallmark of cancer.

Yeung SJ, Pan J, Lee MH.

Cell Mol Life Sci. 2008 Dec;65(24):3981-99. doi: 10.1007/s00018-008-8224-x. Review.

PMID:
18766298
20.

Myc controls transcriptional regulation of cardiac metabolism and mitochondrial biogenesis in response to pathological stress in mice.

Ahuja P, Zhao P, Angelis E, Ruan H, Korge P, Olson A, Wang Y, Jin ES, Jeffrey FM, Portman M, Maclellan WR.

J Clin Invest. 2010 May;120(5):1494-505. doi: 10.1172/JCI38331. Epub 2010 Apr 1.

Items per page

Supplemental Content

Write to the Help Desk